This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.


Prof. Dr. Stefan Stevanović

Review articles



Mester G, Hoffmann V, Stevanovic S (2011) Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell Mol Life Sci 68:1521-1532


Klug F, Miller M, Schmidt HH, Stevanovic S (2009) Characterization of MHC ligands for peptide based tumor vaccination. Curr Pharm Des 15:3221-3236


Schuler MM, Nastke MD, Stevanovic S (2007) SYFPEITHI: Database for searching and T cell epitope prediction. Methods Mol Biol 409:75-93 

Gouttefangeas C, Stenzl A, Stevanovic S, Rammensee HG (2007) Immunotherapy of renal cell carcinoma. Cancer Immunol Immunother 56:117-128


Weinzierl AO, Stevanovic S (2006) LC-MS-based protein and peptide quantification using stable isotope labels. Biotechnol Gen E Rev 23:21-39

Dengjel J, Stevanovic S (2006) Naturally presented MHC ligands carrying glycans. Transfus Med Hemother 33:38-44

Hillen N, Stevanovic S (2006) Contribution of mass spectrometry-based proteomics to immunology. Expert Rev Proteomics 3:653-664

Schmid D, Dengjel J, Schoor O, Stevanovic S, Münz C (2006) Autophagy in innate and adaptive immunity against intracellular pathogens. J Mol Med 28:1-9


Stevanovic S (2005) Antigen processing is predictable: From genes to T cell epitopes. Transpl Immunol 14:171-174

Dengjel J, Rammensee HG, Stevanovic S (2005) Glycan side chains on naturally presented MHC class II ligands. J Mass Spectrom 40:100-104


Stevanovic S, Lemmel C, Häntschel M, Eberle U (2003) Generating data for databases--the peptide repertoire of HLA molecules. Novartis Found Symp 254:143-155

Lemmel C, Stevanovic S (2003) The use of HPLC-MS in T-cell epitope identification. Methods 29:248-259


Rammensee HG, Weinschenk T, Gouttefangeas C, Stevanovic S (2002) Towards patient-specific tumor antigen selection for vaccination. Immunol Rev 188:164-176

Stevanovic S (2002) Structural basis of immunogenicity. Transpl Immunol 10:133-136

Stevanovic S (2002) Identification of tumour-associated T-cell epitopes for vaccine development. Nature Rev Cancer 2:514-520 


Schirle M, Weinschenk T, Stevanovic S (2001) Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J Immunol Methods 257:1-16


Stevanovic S, Schild H (1999) Quantitative aspects of T cell activation: Peptide generation and editing by MHC class I molecules. Sem Immunol 11:375-384

Kanz L, Brossart P, Stuhler G, Reichardt V, Kleihauer A, Scheding S, Stevanovic S, Einsele H, Rammensee HG, Brugger W (1999) Pre-clinical and early clinical experience using dendritic cells to treat human malignancy. Hematol Cell Ther 41:56-57

Münz C, Nickolaus P, Lammert E, Pascolo S, Stevanovic S, Rammensee HG (1999) The role of peptide presentation in the physiological function of HLA-G. Sem Cancer Biol 9:47-54


Stevanovic S, Pomer S, Rammensee HG (1995) Oberflächenantigene im Nierenzellkarzinom - Präsentation von MHC I-gebundenen Selbstpeptiden. Akt Urol 26:S45-S46


Stevanovic S, Rammensee HG (1994) Identification of T-cell epitopes using allele-specific ligand motifs. Behring Inst Mitt 95:7-13


Stevanovic S, Wiesmüller KH, Metzger J, Beck-Sickinger AG, Jung G (1993) Natural and synthetic peptide pools: characterization by sequencing and electrospray mass spectrometry. BioMed Chem Lett 3:431-436